Bronchodilator Responses after Methacholine and Adenosine 5′-Monophosphate (AMP) Challenges in Children with Asthma: Their Relationships with Eosinophil Markers

References

• Ulrick CS, Postma D, Backer V. Recognition of asthma in adolescents and young adults: which objective measure is best? J Asthma 2005; 42:549–554.
   PubMedGoogle Scholar
• Abramson MJ, Walters J, Walters EH. Adverse effects of beta-agonists: are they clinically relevant? Am J Respir Med 2003; 2:287–297.
   PubMedGoogle Scholar
• Cockcroft DW. Direct challenge tests. Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138:18S–24S.
   PubMed Web of Science ®Google Scholar
• Anderson SD. Indirect challenge tests. Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138:25S–30S.
   PubMed Web of Science ®Google Scholar
• Busse WW. The relationship of airway hyperresponsiveness and airway inflammation. Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138:4S–10S.
   PubMed Web of Science ®Google Scholar
• de Meer G, Marks GB, Postma DS. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? Clin Exp Allergy 2001; 34:9–16.
   Google Scholar
• Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142:469–475.
   PubMed Web of Science ®Google Scholar
• Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC. An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol 2010; 45:174–181.
   PubMed Web of Science ®Google Scholar
• Suh DI, Lee JK, Kim CK, Koh YY. Bronchial hyperresponsiveness to methacholine and adenosine 5′-monophosphate, and the presence and degree of atopy in young children with asthma. Clin Exp Allergy 2011; 41:338–345.
   PubMedGoogle Scholar
• Suh DI, Lee JK, Kim CK, Koh YY. Methacholine and adenosine 5′-monophoaphate (AMP) responsiveness, and the presence and degree of atopy in children with asthma. Pediatric Allergy Immunol 2011; 22:e101–e106.
   Google Scholar
• Choi SH, Kim DK, Yu J, Yoo Y, Koh YY. Bronchial responsiveness to methacholine and adenosine 5′-monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein. Allergy 2007; 62:1119–1124.
   PubMedGoogle Scholar
• Bauer S, Park HaN, Seo HS, Kim JiE, Song DJ, Park SH, Choung JiT, Yoo Y, Kim HJ. Assessment of bronchodilator responsiveness following methacholine-induced broncho-constriction in children with asthma. Allergy Asthma Immunol Res 2011; 3:245–250.
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. 1997. Guidelines for the diagnosis and management of asthma: expert panel report 2. National Institutes of Health publication 97–4051. Bethesda, MD: US Department of Health and Human Services.
   Google Scholar
• Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townly RG. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323–327.
   PubMed Web of Science ®Google Scholar
• Joos GF, O’Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R. postma DS, Riedler J: ERS Task Force. Indirect airway challenges. Eur Respir J 2003; 21:1050–1068.
   PubMed Web of Science ®Google Scholar
• Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988; 138:317–320.
   PubMed Web of Science ®Google Scholar
• Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naive asthmatic children. J Pediatr 2007; 151:457–462.
   PubMed Web of Science ®Google Scholar
• Smith AP, Orehek J, Charpin J. Bronchodilator drug tests in normal subjects. Br J Dis Chest 1977; 71:234–236.
   PubMedGoogle Scholar
• American Thoracic Society. Guidelines for methacholine and exercise challenge testing 1999. Am J Respir Crit Care Med 2000; 161:309–329.
   PubMed Web of Science ®Google Scholar
• Parker AL. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction. J Asthma 2004; 41:671–677.
   PubMed Web of Science ®Google Scholar
• Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006; 31:181–196.
   PubMed Web of Science ®Google Scholar
• van der Woude HJ, Winter TH, Aalbers R. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe broncho- constriction during high dose treatment with long-acting β2 agonists. Thorax 2001; 56:529–535.
   PubMed Web of Science ®Google Scholar
• Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR. Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J 1999; 14:283–287.
   PubMed Web of Science ®Google Scholar
• Waalkens HJ, Merkus PJ, van Essen-Zandvliet EE, Brand PL, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol KK, Quanjer PH. Assessment of bronchodilator response in children with asthma. Eur Respir J 1993; 6:645–651.
   PubMed Web of Science ®Google Scholar
• Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med 2008; 14:39–45.
   PubMed Web of Science ®Google Scholar
• Silvestri M, Sabatini F, Sale R, Defilippi AC, Fregonese L, Battistini E, Biraghi MG, Rossi GA. Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. Pediatr Pulmonol 2003; 35:358–363.
   PubMed Web of Science ®Google Scholar
• Faul JL, Demers EA, Burke CM, Poulter LW. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest 2002; 121:1414–1420.
   PubMed Web of Science ®Google Scholar
• Prieto L, Gutierrez V, Colas C, Tabar A, Perez-Frances C, Bruno L, Uixera S. Effect of omalizumab on adenosine 5′-monophosphate responsiveness in subjects with allergic asthma. Int Arch Allergy Immunol 2006; 139:122–131.
   PubMedGoogle Scholar
• Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naïve asthma patients. J Investig Allergol Clin Immunol 2006; 16:239–246.
   PubMed Web of Science ®Google Scholar
• Zielen S, Christmann M, Kloska M, Dogan-Yildiz G, Lieb A, Rosewich M, Schubert R, Rose MA, Schulze J. Predicting short term response to anti-inflammatory therapy in young children with asthma. CMRO 2010; 26:483–492.
   Google Scholar
• Sitkauskiene B, Sakalauskas R, Malakauskas K, Lotvall J. Reversibility to a β2-agonist in COPD: relationship to atopy and neutrophil activation. Respir Med 2003; 97:591–598.
   PubMed Web of Science ®Google Scholar